0001179110-19-001909.txt : 20190214 0001179110-19-001909.hdr.sgml : 20190214 20190214162831 ACCESSION NUMBER: 0001179110-19-001909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190212 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON MICHELLE CENTRAL INDEX KEY: 0001755098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 19606966 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2019-02-12 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001755098 ROBERTSON MICHELLE C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2019-02-12 4 M 0 4870 A 13639 D Common Stock 2019-02-13 4 S 0 1410 12.70 D 12229 D Restricted Stock Units 2019-02-12 4 M 0 4870 0 D Common Stock 4870 4870 D Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Restricted Stock Units convert into common stock on a one-for-one basis. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date. /s/ R. Mark Chamberlin as attorney in fact 2019-02-14